Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 3 1Phase 1/2 1

Status

Completed 6

Sponsor Class

OTHER 6

Study Type

Interventional 6Observational 1

Sponsor

Cancer Type

Breast 38Gynecologic 22Gastrointestinal 19Genitourinary 14Other 12Thoracic 11Other solid neoplasm 8Other hematologic neoplasm 8Tumor-Agnostic 6Head & Neck 6Lymphoid 5Other neoplasm 3Sarcoma 2Plasma cell 2Myeloid 1Endocrine 1Dermatologic 1Classical hematology 1CNS 1

Conditions

Neoplasms 4Neoplasm Metastasis 2

Interventions

pembrolizumab 94Paclitaxel 85Gemcitabine 83Carboplatin 79Docetaxel 60Cisplatin 58Bevacizumab 58Nivolumab 56Fluorouracil 47Capecitabine 46Magnetic Resonance Spectroscopy 44Radiotherapy 41Irinotecan 40Oxaliplatin 38Erlotinib Hydrochloride 37Pemetrexed 34Leucovorin 34Biopsy 34atezolizumab 33Cetuximab 32Standard of Care 31Trastuzumab 28Cyclophosphamide 28Radiosurgery 27Blood Specimen Collection 27Specimen Handling 26Sorafenib 26Ipilimumab 26Everolimus 26olaparib 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Interventional × Counseling × Tumor-Agnostic × Clear all
NCT05847686 2025-11-05

Psilocybin-Assisted Therapy for the Treatment of Cancer-Related Anxiety in Patients With Metastatic Cancer

University of Washington

Phase 1/2 Completed
55 enrolled 11 charts
Tumor-Agnostic

Neoplasm Metastasis

NCT02507804 2023-02-22

PROMs

The Christie NHS Foundation Trust

Phase NA Completed
64 enrolled
Tumor-Agnostic

Neoplasms

NCT04266522 2022-10-07

Medical Physics Direct Patient Care for the Improvement of Patient Understanding of Care

Barbara Ann Karmanos Cancer Institute

Phase NA Completed
45 enrolled
Tumor-Agnostic

Neoplasms

NCT03244202 2018-04-17

Evaluation of a Decision Aid for Incidental Genomic Findings

Unity Health Toronto

Phase NA Completed
133 enrolled
Tumor-Agnostic

Neoplasms

NCT01432431 2013-09-05

Spiritual Care in Improving Quality of Life of Patients, Caregivers, and Hospital Staff

City of Hope Medical Center

Phase NA Completed
100 enrolled
Tumor-Agnostic

Neoplasms

NCT00244868 2013-01-29

Computer-Based Survey and Communication Aid in Improving Physician-Patient Communication and Treatment Decision Making in Patients With Metastatic Cancer

Fox Chase Cancer Center

Phase 3 Completed
720 enrolled
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡